Status:
RECRUITING
Enhancing PTSD Treatment Outcomes by Improving Patient-Provider Communication
Lead Sponsor:
Boston University
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Stress Disorders, Post-Traumatic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this clinical trial is to learn whether existing treatments for posttraumatic stress disorder (PTSD) can be improved. Two treatments for PTSD, cognitive processing therapy (CPT) and pro...
Eligibility Criteria
Inclusion
- Diagnosis of PTSD
- Stable on psychiatric medications for at least 4 weeks
Exclusion
- Current unstable bipolar disorder
- Current psychosis
- Current active suicidal or homicidal ideation with intent or plan
- Current severe substance use that warrants immediate medical attention
- Current trauma-focused treatment
- Significant cognitive impairment that would prevent engagement in assessments and therapy (e.g., advanced dementia, severe traumatic brain injury).
Key Trial Info
Start Date :
January 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT06088303
Start Date
January 15 2025
End Date
December 31 2028
Last Update
April 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Center for PTSD at VA Boston Healthcare System
Boston, Massachusetts, United States, 02130